Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019


Phacilitate Leaders Europe Agenda 2018


Investment panel discussion: Constructing the perfect biotech: how can the ATMP biotech industry attract European, US and Asian investment?

11 Sep 2018
  • European vs US investment. Should biotech strategies change depending on the region they are seeking investment?
  • Recognising a gem in a crowded market. What do you look for in a biotech when investing in ATMP’s?
  • Constructing mutually beneficial partnership strategies between investors and biotechs
  • What’s the next big investment opportunity in ATMPs?
  • How can you make your organisation more appealing to investors
  • How soon is too soon for an IPO?
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd